Generic Firms Must Pay Actos Legal Fees, Partly Because Of Claim Flip-Flops
This article was originally published in The Pink Sheet Daily
Executive Summary
In deciding for Takeda, judge says Mylan and Alphapharm also disregarded court orders and used faulty witnesses during their patent challenges.